Patrick Wood

Stock Analyst at Morgan Stanley

(0)
# 635
Out of 1,030 analysts
77
Total ratings
48.00%
Success rate
3.64%
Average return
22 Stocks
Name Action Price Target Current % Upside Ratings Updated
Cooper Companies
Maintains: Equal-Weight
104 102
94.98 7.39% 5 Dec 6, 2024
Tandem Diabetes Care
Upgrades: Overweight
45 45
32.62 37.95% 3 Dec 2, 2024
Glaukos
Downgrades: Underweight
120
139.69 -14.1% 3 Dec 2, 2024
Bausch & Lomb
Downgrades: Equal-Weight
19
18.55 2.43% 6 Dec 2, 2024
PROCEPT BioRobotics
Initiates Coverage On: Overweight
105
90.01 16.65% 1 Dec 2, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Equal-Weight
60 73
69.65 4.81% 3 Nov 11, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Overweight
234 317
269.46 17.64% 5 Nov 11, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Overweight
92 100
90.34 10.69% 4 Oct 24, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reinstates: Equal-Weight
70
73.38 -4.61% 7 Oct 11, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Equal-Weight
120 75
77.39 -3.09% 6 Jul 26, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Equal-Weight
18 10
13.78 -27.43% 2 Jul 15, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Equal-Weight
104 145
64.59 124.49% 1 Jul 15, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Equal-Weight
65 85
84.19 0.96% 3 Jul 15, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Underweight
50 37
24.86 48.83% 2 Jul 15, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Underweight
39 30
30.39 -1.28% 3 Jul 15, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Equal-Weight
285 335
n/a n/a 6 Apr 8, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Equal-Weight
74 86
81.04 6.12% 5 Feb 12, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Equal-Weight
225 215
214.03 0.45% 3 Dec 4, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Overweight
310 280
226.16 23.81% 3 Dec 4, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Overweight
n/a
n/a n/a 3 Dec 4, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Overweight
36
37.1 -2.96% 1 Dec 4, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Buy
n/a
n/a n/a 2 Dec 11, 2017